BioCentury
ARTICLE | Financial News

Oxford spins out biomarker company

January 19, 2012 1:34 AM UTC

The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer consulting services. CRO Quintiles Transnational Corp. (Research Triangle Park, N.C.) made a L3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. ...